Skip to main content
. 2023 Oct 17;11(10):E992–E1000. doi: 10.1055/a-2157-5034

Fig. 4.

Fig. 4

Adequate mucosal visibility (%) in all patients (n = 260) randomized to either the early group (n = 132) or the late group (n = 128) in relation to the measured time (minutes) of simethicone administration prior to endoscopy. Early group = 40 mg simethicone scheduled at 20 to 30 minutes prior to gastroscopy. Late group = 40 mg simethicone scheduled at 0 to 10 minutes prior to gastroscopy. Of note: patients included in the split-dose group are not represented in this figure. Adequate total mucosal visibility was defined as a score ≤ 2 for all nine of the predefined locations. Adequate mucosal visibility per organ was defined as a score ≤ 2 for each of the respective predefined locations in the esophagus, stomach or duodenum separately.